Patents by Inventor Silvia PRADO MARTÍN

Silvia PRADO MARTÍN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND OTHER DISEASES CAUSED BY RNA VIRUSES
    Publication number: 20210267981
    Abstract: Use of organic compounds for the treatment of the infection caused by human immunodeficiency virus type 1 (HIV-1), as well as other diseases caused by RNA viruses is disclosed.
    Type: Application
    Filed: June 24, 2019
    Publication date: September 2, 2021
    Inventors: Jose GALLEGO SALA, Silvia PRADO MARTIN, Jose ALCAMI PERTEJO
  • Bilaterally-substituted tricyclic compounds for the treatment of human immunodeficiency virus type-1 (HIV-1) infection and other diseases
    Patent number: 9586943
    Abstract: The invention relates to novel bilaterally-substituted tricyclic compounds and pharmaceutical compositions containing them, for use as medicaments. Due to their ability to interact with an internal RNA loop and to mimic a protein ?-helix these compounds are effective in the treatment and/or prevention of HIV-1 (Human Immunodeficiency Virus-1) infection and other diseases such as those caused by other RNA viruses and by gram-positive and gram-negative bacteria, or infectious or chronic diseases responsive to inhibition of DNA transcription, or infectious or chronic diseases where these compounds can be used to modulate the function of RNA internal loops, or infectious or chronic diseases where these compounds can be used as agonists or inhibitors of ?-helical proteins in interaction with other biomolecules.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: March 7, 2017
    Assignees: UNIVERSITAT DE VALÈNCIA, INSTITUTO DE SALUD CARLOS III, UNIVERSIDAD CATÓLICA DE VALENCIA “SAN VINCENTE MÁRTIR”
    Inventors: José Gallego Sala, Santos Fustero Lardiés, José Alcamí Pertejo, Luis González Bulnes, Ignacio Ibañez Sánchez, Silvia Catalán Muñoz, Ángel Cantero Camacho, Pablo Barrio Fernández, Silvia Prado Martín
  • BILATERALLY-SUBSTITUTED TRICYCLIC COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION AND OTHER DISEASES
    Publication number: 20160108024
    Abstract: The invention relates to novel bilaterally-substituted tricyclic compounds and pharmaceutical compositions containing them, for use as medicaments. Due to their ability to interact with an internal RNA loop and to mimic a protein ?-helix these compounds are effective in the treatment and/or prevention of HIV-1 (Human Immunodeficiency Virus-1) infection and other diseases such as those caused by other RNA viruses and by gram-positive and gram-negative bacteria, or infectious or chronic diseases responsive to inhibition of DNA transcription, or infectious or chronic diseases where these compounds can be used to modulate the function of RNA internal loops, or infectious or chronic diseases where these compounds can be used as agonists or inhibitors of ?-helical proteins in interaction with other biomolecules.
    Type: Application
    Filed: February 20, 2014
    Publication date: April 21, 2016
    Inventors: José GALLEGO SALA, Santos FUSTERO LARDIÉS, José ALCAMÍPERTEJO, Luis GONZÁLEZ BULNES, Ignacio IBAÑEZ SÁNCHEZ, Silvia CATALÁN MUÑOZ, Ángel CANTERO CAMACHO, Pablo BARRIO FERNÁNDEZ, Silvia PRADO MARTÍN